A team at Siteman Cancer Center received a federal grant for $10.4 million over five years to fund the research.
“This grant addresses a huge need to improve therapies for pancreatic cancer patients,” said Dr. William Hawkins, professor of surgery and lead investigator on the study, in a statement.
About 75 percent of people who develop pancreatic cancer die within a year of diagnosis, and fewer than 8 percent will live for five years. Tumors in the six-inch organ deep in the abdomen are difficult to find and cause few symptoms before the cancer has spread. By 2021, researchers expect pancreatic cancer to be the second leading cause of cancer death after lung cancer. Read more . . .